ArticleMolecular medicine (Cambridge, Mass.)2023

Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.

Jiayu Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.